Ghrelin relieves cancer cachexia associated with the development of lung adenocarcinoma in mice

European Journal of Pharmacology

Volumn 743, Issue , 2014, Pages 1-10

  Tsubouchi, Hironobu ^a   Yanagi, Shigehisa ^a   Miura, Ayako ^a   Matsumoto, Nobuhiro ^a   Kangawa, Kenji ^b   Nakazato, Masamitsu ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Cachexia; Cancer; Ghrelin; Muscle atrophy

Indexed keywords

ATROGIN 1; C REACTIVE PROTEIN; FORKHEAD BOX PROTEIN O1; FORKHEAD TRANSCRIPTION FACTOR; GHRELIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MUSCLE RING FINGER 1 PROTEIN; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; PROTEIN KINASE B;

ANIMAL CELL; ARTICLE; CACHEXIA; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FAT MASS; HORMONE BLOOD LEVEL; INTRAABDOMINAL FAT; LUNG ADENOCARCINOMA; MUSCLE CONTRACTION; MUSCLE MASS; MUSCLE STRENGTH; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE; SOLEUS MUSCLE; TIBIALIS ANTERIOR MUSCLE; UPREGULATION; WEIGHT REDUCTION; ADENOCARCINOMA; ANIMAL; C57BL MOUSE; COMPLICATION; DRUG EFFECTS; EATING; INFLAMMATION; LUNG NEOPLASMS; MALE; METABOLISM; MOUSE; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ANIMALS; C-REACTIVE PROTEIN; CACHEXIA; EATING; GHRELIN; INFLAMMATION; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-1BETA; INTERLEUKIN-6; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MUSCLE CONTRACTION; MUSCLE, SKELETAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; WEIGHT LOSS;

EID: 84918786476     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.09.025     Document Type: Article

References (44)

1. S. Acharyya, M.E. Butchbach, Z. Sahenk, H. Wang, M. Saji, M. Carathers, M.D. Ringel, R.J. Skipworth, K.C. Fearon, M.A. Hollingsworth, P. Muscarella, A.H. Burghes, J.A. Rafael-Fortney, and D.C. Guttridge Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia Cancer Cell 8 2005 421 432
2. K.M. Baldwin, and C.M. Tipton Work and metabolic patterns of fast and slow twitch skeletal muscle contracting in situ Pflug. Arch. 334 1972 345 356
3. R.J. Bodnar, G.W. Pasternak, P.E. Mann, D. Paul, R. Warren, and D.B. Donner Mediation of anorexia by human recombinant tumor necrosis factor through a peripheral action in the rat Cancer Res. 49 1989 6280 6284
4. M. Brink, S.R. Price, J. Chrast, J.L. Bailey, A. Anwar, W.E. Mitch, and P. Delafontaine Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I Endocrinology 142 2001 1489 1496
5. D. Cai, J.D. Frantz, N.E. Tawa Jr., P.A. Melendez, B.C. Oh, H.G. Lidov, P.O. Hasselgren, W.R. Frontera, J. Lee, D.J. Glass, and S.E. Shoelson IKKbeta/NF-kappaB activation causes severe muscle wasting in mice Cell 119 2004 285 298
6. M.D. DeBoer, X.X. Zhu, P. Levasseur, M.M. Meguid, S. Suzuki, A. Inui, J.E. Taylor, H.A. Halem, J.Z. Dong, R. Datta, M.D. Culler, and D.L. Marks Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia Endocrinology 148 2007 3004 3012
7. V.D. Dixit, E.M. Schaffer, R.S. Pyle, G.D. Collins, S.K. Sakthivel, R. Palaniappan, J.W. Lillard Jr., and D.D. Taub Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells J. Clin. Invest. 114 2004 57 66
8. K.C. Fearon Cancer cachexia: developing multimodal therapy for a multidimensional problem Eur. J. Cancer 44 2008 1124 1132
9. K.C. Fearon, D.J. Glass, and D.C. Guttridge Cancer cachexia: mediators, signaling, and metabolic pathways Cell Metab. 16 2012 153 166
10. J.M. Garcia, J. Friend, and S. Allen Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study Support. Care Cancer 21 2013 129 137
11. T. Hanada, K. Toshinai, N. Kajimura, N. Nara-Ashizawa, T. Tsukada, Y. Hayashi, K. Osuye, K. Kangawa, S. Matsukura, and M. Nakazato Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells Biochem. Biophys. Res. Commun. 301 2003 275 279
12. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa Ghrelin is a growth-hormone-releasing acylated peptide from stomach Nature 402 1999 656 660
13. K. Koshinaka, K. Toshinai, A. Mohammad, K. Noma, M. Oshikawa, H. Ueno, H. Yamaguchi, and M. Nakazato Therapeutic potential of ghrelin treatment for unloading-induced muscle atrophy in mice Biochem. Biophys. Res. Commun. 412 2011 296 301
14. J.M. Kristensen, J.T. Treebak, P. Schjerling, L. Goodyear, and J.F. Wojtaszewski Two weeks of metformin treatment induces AMPK-dependent enhancement of insulin-stimulated glucose uptake in mouse soleus muscle Am. J. Physiol. Endocrinol. Metab. 306 2014 E1099 E1109
15. K.M. Lai, M. Gonzalez, W.T. Poueymirou, W.O. Kline, E. Na, E. Zlotchenko, T.N. Stitt, A.N. Economides, G.D. Yancopoulos, and D.J. Glass Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy Mol. Cell. Biol. 24 2004 9295 9304
16. A. Laviano, M.M. Meguid, and F. Rossi-Fanelli Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies Lancet Oncol. 4 2003 686 694
17. Y.P. Li, Y. Chen, J. John, J. Moylan, B. Jin, D.L. Mann, and M.B. Reid TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle FASEB J. 19 2005 362 370
18. P.R. Ling, J.H. Schwartz, and B.R. Bistrian Mechanisms of host wasting induced by administration of cytokines in rats Am. J. Physiol. 272 1997 E333 E339
19. A.M. Malkinson, and D.S. Beer Major effect on susceptibility to urethan-induced pulmonary adenoma by a single gene in BALB/cBy mice J. Natl. Cancer Inst. 70 1983 931 936
20. G. Mantovani, A. Maccio, P. Lai, E. Massa, M. Ghiani, and M.C. Santona Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate Semin. Oncol. 25 1998 45 52
21. C.J. Marsit, S. Zheng, K. Aldape, P.W. Hinds, H.H. Nelson, J.K. Wiencke, and K.T. Kelsey PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration Hum. Pathol. 36 2005 768 776
22. R. Moore-Carrasco, S. Busquets, V. Almendro, M. Palanki, F.J. Lopez-Soriano, and J.M. Argiles The AP-1/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia Int. J. Oncol. 30 2007 1239 1245
23. N. Nagaya, T. Itoh, S. Murakami, H. Oya, M. Uematsu, K. Miyatake, and K. Kangawa Treatment of cachexia with ghrelin in patients with COPD Chest 128 2005 1187 1193
24. N. Nagaya, J. Moriya, Y. Yasumura, M. Uematsu, F. Ono, W. Shimizu, K. Ueno, M. Kitakaze, K. Miyatake, and K. Kangawa Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure Circulation 110 2004 3674 3679
25. N. Nagaya, M. Uematsu, M. Kojima, Y. Ikeda, F. Yoshihara, W. Shimizu, H. Hosoda, Y. Hirota, H. Ishida, H. Mori, and K. Kangawa Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure Circulation 104 2001 1430 1435
26. R. Northrup, K. Kuroda, E.M. Duus, S.R. Barnes, L. Cheatham, T. Wiley, and C. Pietra Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model Support. Care Cancer 21 2013 2409 2415
27. A.K. Perl, S.E. Wert, A. Nagy, C.G. Lobe, and J.A. Whitsett Early restriction of peripheral and proximal cell lineages during formation of the lung Proc. Natl. Acad. Sci. USA. 99 2002 10482 10487
28. A.H. Pullen The distribution and relative sizes of three histochemical fibre types in the rat tibialis anterior muscle J. Anat. 123 1977 1 19
29. A.G. Renehan, M. Zwahlen, C. Minder, S.T. O'Dwyer, S.M. Shalet, and M. Egger Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis Lancet 363 2004 1346 1353
30. B. Sauer Inducible gene targeting in mice using the Cre/lox system Methods 14 1998 381 392
31. Y.H. Song, Y. Li, J. Du, W.E. Mitch, N. Rosenthal, and P. Delafontaine Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting J. Clin. Invest. 115 2005 451 458
32. F. Strasser, T.A. Lutz, M.T. Maeder, B. Thuerlimann, D. Bueche, M. Tschop, K. Kaufmann, B. Holst, M. Brandle, R. von Moos, R. Demmer, and T. Cerny Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study Br. J. Cancer 98 2008 300 308
33. M. Sugiyama, A. Yamaki, M. Furuya, N. Inomata, Y. Minamitake, K. Ohsuye, and K. Kangawa Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice Regul. Pept. 178 2012 21 28
34. A. Suzuki, M.T. Yamaguchi, T. Ohteki, T. Sasaki, T. Kaisho, Y. Kimura, R. Yoshida, A. Wakeham, T. Higuchi, M. Fukumoto, T. Tsubata, P.S. Ohashi, S. Koyasu, J.M. Penninger, T. Nakano, and T.W. Mak T cell-specific loss of Pten leads to defects in central and peripheral tolerance Immunity 14 2001 523 534
35. J.M. Tang, Q.Y. He, R.X. Guo, and X.J. Chang Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis Lung Cancer 51 2006 181 191
36. M.M. Theil, S. Miyake, M. Mizuno, C. Tomi, J.L. Croxford, H. Hosoda, J. Theil, S. von Horsten, H. Yokote, A. Chiba, Y. Lin, S. Oki, T. Akamizu, K. Kangawa, and T. Yamamura Suppression of experimental autoimmune encephalomyelitis by ghrelin J. Immunol. 183 2009 2859 2866
37. M.J. Tisdale Cachexia in cancer patients Nat. Rev. Cancer 2 2002 862 871
38. M. Tschop, D.L. Smiley, and M.L. Heiman Ghrelin induces adiposity in rodents Nature 407 2000 908 913
39. H. Tsubouchi, S. Yanagi, A. Miura, S. Iizuka, S. Mogami, C. Yamada, T. Hattori, and M. Nakazato Rikkunshito ameliorates bleomycin-induced acute lung injury in a ghrelin-independent manner Am. J. Physiol. Lung Cell. Mol. Physiol. 306 2014 L233 L245
40. S.E. Wert, S.W. Glasser, T.R. Korfhagen, and J.A. Whitsett Transcriptional elements from the human SP-C gene direct expression in the primordial respiratory epithelium of transgenic mice Dev. Biol. 156 1993 426 443
41. D. Yamamoto, N. Ikeshita, T. Matsubara, H. Tasaki, E.H. Herningtyas, K. Toda, K. Iida, Y. Takahashi, H. Kaji, K. Chihara, and Y. Okimura GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the dexamethasone-induced expressions of muscle-specific ubiquitin ligases, Atrogin-1 and MuRF1 Life Sci. 82 2008 460 466
42. S. Yanagi, H. Kishimoto, K. Kawahara, T. Sasaki, M. Sasaki, M. Nishio, N. Yajima, K. Hamada, Y. Horie, H. Kubo, J.A. Whitsett, T.W. Mak, T. Nakano, M. Nakazato, and A. Suzuki Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice J. Clin. Invest. 117 2007 2929 2940
43. T. Yasuda, T. Masaki, T. Kakuma, and H. Yoshimatsu Centrally administered ghrelin suppresses sympathetic nerve activity in brown adipose tissue of rats Neurosci. Lett. 349 2003 75 78
44. X. Zhou, J.L. Wang, J. Lu, Y. Song, K.S. Kwak, Q. Jiao, R. Rosenfeld, Q. Chen, T. Boone, W.S. Simonet, D.L. Lacey, A.L. Goldberg, and H.Q. Han Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival Cell 142 2010 531 543